Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Promises, Pitfalls, and Paths Forward for the Pediatric Research Equity Act.

JAMA health forum·2026

Same author

Alcohol and the Cerebellum: Effects on Balance, Motor Coordination, and Cognition.

Alcohol health and research world·2019

Same author

Androgen deficiency in males.

Expert review of endocrinology & metabolism·2019

Same author

Regional striatal volume abnormalities in schizophrenia: effects of comorbidity for alcoholism, recency of alcoholic drinking, and antipsychotic medication type.

Schizophrenia research·2005

Same author

Striatal and forebrain nuclei volumes: contribution to motor function and working memory deficits in alcoholism.

Biological psychiatry·2005

Same author

Clinical information management systems: an emerging data technology for inpatient pharmacies.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2004

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Low testosterone and the association with type 2 diabetes.

Joanne B Farrell¹, Anjali Deshmukh¹, Ali A Baghaie¹

¹Solvay Pharmaceuticals, Inc, Marietta, Georgia

The Diabetes Educator

|October 4, 2008

Summary

Androgen deficiency, or male hypogonadism, is linked to metabolic syndrome and type 2 diabetes. Early diagnosis and treatment are crucial for managing this common endocrine disorder in men.

Area of Science:

Endocrinology
Metabolic Disorders
Men's Health

Background:

Androgen deficiency (male hypogonadism) is an underdiagnosed endocrine disorder.
It is increasingly recognized for its association with metabolic syndrome and type 2 diabetes.
Prevalence, screening, diagnosis, treatment, and monitoring are essential aspects of managing this condition.

Purpose of the Study:

To describe androgen deficiency in men.
To explore its consequences, particularly its relationship with metabolic syndrome and type 2 diabetes.
To provide an overview of the clinical management of male hypogonadism.

Main Methods:

Literature review from 1990 to 2007.
Analysis of 26 studies.
Databases searched included CINAHL, PubMed, and MEDLINE.

Related Experiment Videos

Last Updated: Jun 29, 2026

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

Main Results:

A link exists between low testosterone levels and an adverse metabolic profile, including obesity and insulin resistance.
Evidence supports the association between hypogonadism and metabolic syndrome in men.
Hypogonadism is linked to the development of type 2 diabetes.

Conclusions:

Male hypogonadism affects a significant number of men, potentially up to 50% of those with type 2 diabetes.
Diabetes educators must understand male hypogonadism to guide patients and coordinate care.
Increased awareness and understanding are needed for effective patient management.